Navigation Links
Terumo Medical Corporation Announces its Program for the Global Embolization Symposium and Technologies (GEST) Meeting

Terumo Medical Corporation Announces its Program for the Global Embolization Symposium and Technologies (GEST) Meeting. Focus is on Benefit of Embolization Using AZUR® Peripheral Hydrocoil® System

Somerset, NJ (PRWEB) May 5, 2010 -- Terumo Medical Corporation, a U.S.-based subsidiary of Terumo Corporation, today announced its educational program for the 4th Annual Global Embolization Symposium and Technologies (GEST) Meeting, May 6 to 9, in San Francisco, CA.
Terumo’s primary focus at this meeting is the AZUR® Peripheral Hydrocoil® Embolization System.

GEST, which is the largest embolization meeting of its kind, is being held in the United States for the first time. Terumo is one of three primary sponsors of the 2010 meeting.

Terumo will host a lunchtime symposium on Thursday, May 6, beginning at 12:00 p.m. The program will feature three prominent physicians, including the first presentation of Dr. Craig Greben’s recently published article in Vascular and Endovascular Surgery (44(3) 217-222, March 2010) on the Double Micro Catheter Technique:   

  • Watertight Occlusion of the Gastroduodenal Artery. Steven C. Rose, M.D. Professor of Clinical Radiology, Section Chief Interventional Oncology, University of California, San Diego Medical Center, San Diego, California.
  • AZUR in the Periphery: The MUSC Experience. Marcelo Guimaraes, M.D. Assistant Professor, Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, South Carolina.
  • The Use of Hydrogel Coated Coils in the Periphery: The North Shore Medical Center Experience. Craig Greben, M.D. Chief, Division of Vascular and Interventional Radiology, North Shore University Hospital, Manhasset, New York.

“Detachable coil technology has significantly expanded the treatment pool of patients I can intervene on safely,” said Dr. Greben. “It provides for precise placement and significantly impacts my clinical options.”

GEST attendees will have the opportunity to gain hands-on experience with Terumo’s AZUR Detachable 35, the first of its kind and Terumo’s latest embolic product. The Detachable 35 affords the same control as the Detachable 18, but provides more volume, thereby expanding treatment opportunities in areas like pre-EVAR embolization (hypogastrics), aneurysms, arterio-venous malformations (AVMs), arterio-venous fistulas (AVFs), among others.

“We are proud to support this international meeting and to demonstrate Terumo’s commitment to the market, as well as our dedication to bringing forward new technologies that can improve patient outcomes and expand a physician’s treatment options,” said Fernando Yuste, Senior Marketing Manager, Terumo Interventional Systems. “We look forward to introducing the AZUR Detachable 35 at this meeting.”

Terumo Associates will be available at the Terumo exhibit booth (#20) to answer questions and to engage with healthcare professionals interested in experiencing the AZUR Detachable 35 in particular and other AZUR technologies in a vessel model. In addition, there are two one-hour “Hands-on Sessions”, which will include AZUR products, held on May 6 at 1:45 p.m. and 2:45 p.m.

Terumo Interventional Systems
Terumo Interventional Systems (TIS), a strategic business unit of Terumo Medical Corporation, directly markets a full line of guidewires, catheters, introducer sheaths, guiding sheaths and embolization products for use in a multitude of different interventional procedures.
Interventional Radiologists, Interventional Neuroradiologists, Interventional Cardiologists, and Vascular Surgeons are among the medical professionals that depend upon TIS products to access and cross difficult-to-reach lesions, thereby allowing therapeutic intervention in previously unreachable vascular beds.

For more information, customers can contact Terumo Interventional Systems by calling its Inside Sales Team at 800.862.4143 or visit

Terumo Medical Corporation
Founded in 1972 as a Terumo Corporation subsidiary, Terumo Medical Corporation (TMC) develops, manufactures, and markets high-quality medical devices used in a broad range of applications in numerous healthcare markets. TMC manufactures a broad portfolio of needles and syringes, entry-site management products, and a line of sterile connection devices used in hospitals and blood banks worldwide.

Terumo Corporation
Tokyo-based Terumo Corporation is one of the world’s leading medical device manufacturers with $3.0 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures, and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures, and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the healthcare market and by responding to the needs of healthcare providers and the people they serve. Terumo Corporation’s shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol , or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan’s leading stock index.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. U.S. Physician Demand for Transradial Access Education on the Rise New Transradial Access Site from Terumo Medical Corporation Supports Educational Need
2. Oralflo Pill Swallowing Cup Wins Medical Design Excellence Award, Helps Autism Spectrum Kids and Dysphagia Sufferers Take Medications With No Problem
3. All Time Medical Has Just Moved To Their New, State-Of-The Art Office Situated In The Heart Of The Business District Of Monsey, N.Y
4. Grantham University Announces New Certificate of Learning in Medical Coding and Billing
5. UniqueU Medical Weight Loss Success Requires an Expansion and Move to a Larger Location
6. Pay-for-performance programs may worsen medical disparities, study finds
7. Many Non-U.S. Firms Affected by U.S. FDA Import Alert 80-04 for Medical Glove Manufacturing Defects, According to, LLC
8. NIH awards $10 million to Rush University Medical Center to address health disparities
9. HealthCare Partners Medical Group Expands to Orange County. HealthCare Partners and Talbert Medical Group Join Forces
10. Experts from Children's National Medical Center to present at Pediatric Academic Societies' Annual Meeting
11. Advocate Christ Medical Center Presented The 2009 Morehead Apex Workplace of Excellence Award
Post Your Comments:
(Date:11/24/2015)... ... 2015 , ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the FDA, ... , FDA has long asserted that design and manufacture of Laboratory Developed Tests (LDTs) ... not meet the device regulations. , Come up short in an inspection and the ...
(Date:11/24/2015)... Richey, FL (PRWEB) , ... November 24, 2015 , ... ... deems a growing epidemic as deaths from prescription opioids in the United States grew ... and cocaine. In 2013 alone, opioids were involved in 37 percent of all fatal ...
(Date:11/24/2015)... ... November 24, 2015 , ... American Family Care (AFC), the ... of a holiday pop-up clinic located in Metro Atlanta’s North Point Mall. The clinic ... and different way. The location is scheduled to operate through Dec. 24. , Holiday ...
(Date:11/24/2015)... CA (PRWEB) , ... November 24, 2015 , ... Cold Shoulder , LLC launched ... Kickstarter last week and hit their goal of $20,000 in under 10 hours. ... aims to bring the new PRO Weight Loss Vest to the market. , The PRO ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... its exceptional customer service: the TrustDale certification. The award recognizes good companies for ... stone honing , tile and grout, and hard surface restoration company earned this ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... Connecticut , November 24, 2015 ... of Acadiana has entered into a multi-year agreement ... imaging centers. This investment will provide the Breast Center ... --> Sectra (STO: SECT B) announces that ... agreement to deploy Breast Imaging PACS in its ...
(Date:11/24/2015)... , Nov. 24, 2015  Ascendant Solutions, Inc. (Pink Sheets: ... its Board of Directors has declared a special 1 percent ... dividend is payable December 14, 2015, to shareholders of record ... form of additional shares of common stock. ... Board is a strong endorsement of our confidence in Ascendant,s ...
(Date:11/24/2015)... -- iRhythm Technologies, Inc. , a leading digital health care ... will participate in the 27th Annual Piper Jaffray Healthcare Conference at ... . Kevin King , Chief Executive Officer of ... 8:50am ET. --> --> ... . --> iRhythm is a privately held ...
Breaking Medicine Technology: